Polpharma Biologics has two streams of business, the development, and partnerships of our own molecules and providing top-quality contract development and manufacturing solutions to the industry to advance their biological pipeline of biosimilars and novel biologics.
Both our business streams are focused on our ambition to get effective and safe medicines to patients, and we care as much about our partners molecules as we do our own. Work on both our own pipeline and those of our partners takes place at multiple international centers of excellence in Poland and the Netherlands.
Biologics portfolio & partnerships
Polpharma Biologics has its own pipeline of biosimilar and novel therapeutics for out-licensing.
We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars or novel therapeutics.
Contract development & manufacturing capabilities
We have all the required capabilities to support academic, small biotech and large pharma's biologic development projects from early stage discovery through to commercial supply.
Our greatest strength is our integration, being able to support entire projects with greater efficiency and full control on quality and performance, from cell line, process and analytical development to full GMP manufacturing of drug substance and drug product, including sterile fill & finish. Our services are available for both mammalian and microbial expression systems.